Poland wants to increase drug production, reduce imports

AI Summary

Poland’s government has proposed changing medicine reimbursement rules to lower patient costs by up to 30% for drugs manufactured domestically. The draft, adopted by the cabinet on October 27, is intended to take effect on January 1, 2027, subject to legislative approval, and aims to encourage local production and reduce imports.

Poland’s government has proposed changes to drug reimbursement rules that could reduce patient costs for medicines manufactured in Poland by up to 30%. The cabinet adopted the draft on October 27, and the measures are intended to take effect on January 1, 2027, subject to legislative approval.